default author photo

Tyman Stanford

University of South Australia - Quality Use of Medicines and Pharmacy Research Center

SCHOLARLY PAPERS

1

DOWNLOADS

75

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis

Number of pages: 40 Posted: 12 Jul 2022
The University of Hong Kong - Centre for Safe Medication Practice and Research, The University of Hong Kong - Centre for Safe Medication Practice and Research, University of South Australia - Quality Use of Medicines and Pharmacy Research Center, University of Cincinnati - Department of Pharmacy, University of South Australia - Quality Use of Medicines and Pharmacy Research Center, University of South Australia - Quality Use of Medicines and Pharmacy Research Center, University of South Australia - Quality Use of Medicines and Pharmacy Research Center, National Cheng Kung University - Institute of Clinical Pharmacy and Pharmaceutical Sciences, Sungkyunkwan University - Department of Biohealth Regulatory Science, The University of Hong Kong - Department of Medicine, The University of Hong Kong - Centre for Safe Medication Practice and Research, The University of Hong Kong - Department of Medicine, Tianjin University - School of Pharmaceutical Science and Technology, The University of Hong Kong - Queen Mary Hospital, The University of Hong Kong - Department of Medicine, The University of Hong Kong - Department of Medicine, The University of Hong Kong - Centre for Safe Medication Practice and Research and The University of Hong Kong - Centre for Safe Medication Practice and Research
Downloads 75 (844,901)
Citation 1

Abstract:

Loading...

Biosimilar, Interrupted Time-Series Analysis, Quasi experiment, Infliximab, Consumption, Listed Price, Drug policy, Economics